Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas
- PMID: 1353411
Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas
Abstract
Previous studies have shown frequent allelic losses of chromosomes 9p, 10, 17p, and 22q in glial tumors. Other researchers have briefly reported that glial tumors may also show allelic losses of chromosome 19, suggesting a putative tumor suppressor gene locus on this chromosome (D. T. Ransom et al., Proc. Am. Assoc. Cancer Res., 32:302, 1991). To evaluate whether loss of chromosome 19 alleles is common in glial tumors of different types and grades, we performed Southern blot restriction fragment length polymorphism analysis for multiple chromosome 19 loci in 122 gliomas from 116 patients. Twenty-nine tumors had loss of constitutional heterozygosity of 19q, and four tumors had partial deletions of 19q. Allelic losses on 19q were restricted to grade III anaplastic astrocytomas (4/9) and grade IV glioblastomas (11/46), grade II oligodendrogliomas (2/5) and grade III anaplastic oligodendrogliomas (2/2), and grade II (5/8) and grade III (5/7) mixed oligoastrocytomas. These data demonstrate genetic similarities between astrocytomas, oligodendrogliomas, and mixed glial tumors and indicate the presence of a glial tumor suppressor gene on chromosome 19q.
Similar articles
-
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.Clin Cancer Res. 2005 Feb 1;11(3):1119-28. Clin Cancer Res. 2005. PMID: 15709179
-
Molecular genetic evidence for subtypes of oligoastrocytomas.J Neuropathol Exp Neurol. 1997 Oct;56(10):1098-104. doi: 10.1097/00005072-199710000-00003. J Neuropathol Exp Neurol. 1997. PMID: 9329453
-
[Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].Ugeskr Laeger. 2006 Oct 30;168(44):3813-6. Ugeskr Laeger. 2006. PMID: 17118240 Danish.
-
[Histological and molecular classification of gliomas].Rev Neurol (Paris). 2008 Jun-Jul;164(6-7):505-15. doi: 10.1016/j.neurol.2008.03.011. Epub 2008 Jun 10. Rev Neurol (Paris). 2008. PMID: 18565348 Review. French.
-
Genetic alterations associated with glioma progression.Verh Dtsch Ges Pathol. 1994;78:43-7. Verh Dtsch Ges Pathol. 1994. PMID: 7534015 Review.
Cited by
-
Chromosome 1p deletion in colorectal cancer and lower grade glioma: possible relationship with the enteric nervous system.medRxiv [Preprint]. 2023 Dec 22:2023.11.07.23298214. doi: 10.1101/2023.11.07.23298214. medRxiv. 2023. PMID: 38196589 Free PMC article. Preprint.
-
Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas.Brain Pathol. 2013 May;23(3):311-8. doi: 10.1111/bpa.12003. Epub 2012 Nov 29. Brain Pathol. 2013. PMID: 23107103 Free PMC article.
-
Genetic alterations associated with the evolution and progression of astrocytic brain tumours.Virchows Arch. 1995;427(2):113-8. doi: 10.1007/BF00196514. Virchows Arch. 1995. PMID: 7582239 Review.
-
Comparative genetic analysis of metachronous anaplastic oligoastrocytomas with extended recurrence-free interval.J Neurooncol. 2005 Apr;72(2):95-102. doi: 10.1007/s11060-004-3347-x. J Neurooncol. 2005. PMID: 15925987
-
Genetic signature of oligoastrocytomas correlates with tumor location and denotes distinct molecular subsets.Am J Pathol. 2002 Jul;161(1):313-9. doi: 10.1016/S0002-9440(10)64183-1. Am J Pathol. 2002. PMID: 12107116 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Molecular Biology Databases